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 The polyhydroxylated alkaloids uniflorines A and B were isolated in 2000 
from the leaves of the tree Eugenia uniflora L. The common name for this tree is 
Surinam Cherry and the water soluble extracts of its leaves have been used as an 
antidiabetic agent in Paraguayan traditional medicine. Uniflorines A and B showed 
moderate activity in inhibiting the α-glucosidases, rat intestinal maltase (IC50 values 
of 12 and 4.0 µM, respectively) and sucrase (IC50 values of 3.1 and 1.8 µM, 
respectively). Uniflorines A and B were deduced from NMR analysis to have 
pentahydroxyindolizidine structures. In 2004 Davis and Pyne reported the synthesis 
of the proposed structure of uniflorine A. Unfortunately, the NMR spectroscopic data 
of this synthetic material did not match with those of natural uniflorine A. Davis and 
Pyne then assumed that the structure of uniflorine A must be a diastereomer of the 
initially proposed structure. Several other diastereomers of the proposed structure, 
that were epimeric in the A-ring, have been synthesised by other researchers. One 
remaining A-ring diastereomer was the C-2 epimer of the proposed structure. In 
Chapter 2 of this thesis we report the synthesis of this compound in 11 synthetic 
steps and in 0.5% overall yield from L-xylose. However the NMR spectroscopic data 
for this synthesic compound did not match with those of the natural product.  
We then re-examined the NMR spectroscopic data of the natural product and revised 
the structures of uniflorines A and B from initially proposed 
pentahydroxyindolizidines to 1,2,6,7-tetrahydroxy-3-hydroxymethylpyrrolizidines. 
Uniflorine B was the known alkaloid casuarine, while uniflorine A was tentatively 
assigned as 6-epi-casuarine. This was confirmed by the synthesis of the enantiomer 
of 6-epi-casuarine and then 6-epi-casuarine itself. These syntheses are reported in 
Chapters 2.2 and 2.3. The total synthesis of uniflorine A (6-epi-casuarine) was 
achieved in 11 steps and in 13% overall yield from L-xylose. The NMR 
spectroscopic data of this synthetic compound matched with those of the natural 
product uniflorine A. Thus we had successfully determined the correct structures of 
uniflorines A and B.  
Glycosidase inhibitor testing of uniflorine A at 143 µM showed it had 94-97% 
inhibition against the α-D-glucosidases of Saccharomyces cerevisiae and Bacillus 
sterothermophilus and the amyloglucosidase of Aspergillus niger. The IC50 values 
xviii 
 
were only determinated for the two aforementioned α-D-glucosidases and were found 
to be modest at 34 and 28 µM, respectively.  
 In addition, we describe a flexible method for the diastereoselective total 
synthesis of several natural and unnatural polyhydroxylated indolizidines and 
pyrrolizidines from a common precursor.  
The synthesis of the alkaloid casuarine, which was obtained in total of 13 
synthetic steps and in 8% overall yield from L-xylose, is described in Chapter 3. A 
key step in this synthesis was a regioselective epoxide ring-opening reaction with 
hydrogensulfate ion. This reaction secured the correct configurations at C-6 and C-7 
of the target molecule.  
In Chapter 4 we describe the successful synthesis of australine in a total of 14 
steps and 6% overall yield from from L-xylose. Key steps in this synthesis were a 
regioselective epoxide ring-opening reaction with LiAlH4 followed by a Mitsunobu 
reaction that secured the correct configuration C-7 of the target molecule. 
 The synthesis of the natural product 3-epi-casuarine was completed in 13 
steps and in 0.4% overall yield. This synthesis required an inversion of configuration 
at C-3’ of the butyl side chain which was achieved using the Mitsunobu reaction. The 
low overall yield was due to a low yielding epoxide ring-opening reaction due to a 
competing intramolecular epoxide ring-opening reactions involving the 3-α-
hydroxymethyl substituent.  
Natural 3-epi-australine was obtained in total of 14 synthetic steps and in 2% 
overall yield, all from L-xylose. This synthesis required an inversion of configuration 
at C-3’ of the butyl side chain which was achieved using the Mitsunobu reaction. 
Key steps in this synthesis were a regioselective epoxide ring-opening reaction with 
LiAlH4 followed by a Mitsunobu reaction that secured the correct configuration C-7 
of the target molecule.  
From this work a number of novel unnatural indolizidine and pyrrolizidine 
compounds were also obtained as side products. Some of these compounds were 
screened against 10 different glycosidases at 800 µg/mL. Unfortunately, none 
showed strong inhibition with only four compounds showing approximately 40-50% 
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